Latent Tuberculosis Infection Detection Market Safeguarding Public Health: The Rise of the Latent TB Detection Market

Latent Tuberculosis Infection Detection Market worth $2.37 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Latent Tuberculosis Infection Detection Market - (By Brand (QFT-Plus), By Test Type (Tuberculin Skin Test (TST), Interferon Gamma Release Assay (IGRA)), By Application, By End-use), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Latent Tuberculosis Infection Detection Market is valued at US$ 1.53 Bn in 2023, and it is expected to reach US$ 2.37 Bn by 2031, with a CAGR of 5.7% during the forecast period of 2024-2031.

Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/2579

A condition known as latent tuberculosis infection (LTBI) occurs when a person has a Mycobacterium tuberculosis infection but shows no signs of active illness. Identifying LTBI to stop the spread of active tuberculosis (TB) is essential. The growing likelihood of contracting active tuberculosis and increased public awareness of the need for early diagnosis of tuberculosis infection are the main drivers of market expansion.

Significant increases in the geriatric population and an increasing rate of tuberculosis among the elderly are essential drivers of growth. Growth in the market is anticipated due to the rising risk of tuberculosis and growing awareness of early detection. Throughout the forecast period, government activities supporting awareness campaigns to battle tuberculosis and developing innovative diagnostic technologies are also anticipated to contribute to market growth considerably.

The manufacturing and marketing of diagnostic instruments and tests for identifying latent tuberculosis infections are the focus of this market. The term "long-term bacterial infection" (LTBI) describes a state in which people have contracted the tuberculosis germs but do not yet show any symptoms. This market has grown due to the growing worldwide burden of tuberculosis and the demand for early detection and prevention.

Diagnostic instruments like tuberculin skin tests (TSTs) and interferon-gamma release assays (IGRAs) are frequently used to detect LTBI. It is projected that the need for precise and trustworthy LTBI detection techniques will fuel additional market expansion as governments and healthcare institutions throughout the globe step up their efforts to stop the spread of tuberculosis.

List Of Prominent Players In The Latent Tuberculosis Infection Detection Market:
• QIAGEN
• BIOMÉRIEUX
• Oxford Immunotec
• SD Biosensor, INC.
• Wantai BioPharm
• Lionex GmbH
• Sanofi
• Serum Institute of India Pvt. Ltd
• ARKRAY, Inc.
• Par Pharmaceutical, Inc.
• Abbott,
• F. Hoffmann-La Roche Ltd
• Other Prominent Players

Market Dynamics:

Drivers-
One of the most important drivers impacting the global latent tuberculosis infection testing market is the ageing population. Since aged people are highly prone to having latent TB infection as an underlying illness, age-related immune function and increased frequency of adverse drug reactions can complicate the overall clinical approach to tuberculosis in elderly patients.

Moreover, the market has been rising over the past few years because of factors such as rapid urbanization, surging prevalence of HIV, accelerating TB funding, accelerating construction activities, rise in consumer spending, escalating government initiatives, and many other factors.

Challenges:
The latent tuberculosis infection detection market faces challenges such as multidrug-resistant tuberculosis (MDR-TB) and stringent government regulations. MDR-TB complicates treatment and increases the urgency for accurate and timely detection methods.

Stringent regulations can impact market entry for new diagnostic technologies and limit the adoption of innovative solutions. Overcoming these challenges requires research into effective detection techniques, collaboration with regulatory bodies to streamline approval processes, and education programs to raise awareness about the importance of early detection and treatment of latent tuberculosis infections.

Regional Trends:
The North American latent tuberculosis infection (LTBI) detection market is predicted to upgrade due to increasing awareness and initiatives for TB control. The factors driving the market include advancements in diagnostic techniques, the rising prevalence of TB, and support from government health agencies.

The market is also influenced by the presence of major players investing in research and development to improve detection accuracy. Additionally, efforts to implement comprehensive screening programs in high-risk populations contribute to the market's expansion in this region. Besides, Europe had a good share of the market, which was attributed to the presence of major research institutes and key market players.

Curious About This Latest Version Of The Report? Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/2579

Recent Developments:

• In March 2024, QIAGEN formed a cooperation with the International Panel Physicians Association (IPPA) to provide education and assistance to panel physicians throughout the world regarding the most up-to-date tuberculosis screening needs. The primary emphasis will be on the novel IGRA prerequisites and their advantageous implications for patients and healthcare professionals.

Segmentation of latent tuberculosis infection detection market-
By Brand -
• QFT-Plus (QuantiFERON-TB Gold Plus)
• Others
By Test Type -
• Tuberculin Skin Test (TST)
• Interferon Gamma Release Assay (IGRA)
By Application -
• Household Contacts with Pulmonary TB
• PLHIV
• Others
By End-Use -
• Diagnostic Laboratories
• Hospitals/Clinics
• Academic & Research Institutions
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

For More Customization @ https://www.insightaceanalytic.com/customisation/2579

Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.
Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.